Method for establishing pulmonary fibrosis rhesus monkey model
A pulmonary fibrosis and animal model technology, applied in the field of animal models, can solve the problems of injury, many times of administration, and complicated modeling methods, and achieve the effects of obvious pulmonary fibrosis, simple production and broad application prospects.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] The preparation method of embodiment 1 secondary pulmonary fibrosis animal model
[0030] 1. Materials and methods:
[0031] 1.1 Experimental materials
[0032] Three 3-4-year-old female and male rhesus monkeys, free from herpes B virus, simian retrovirus, simian leukemia virus and immunodeficiency virus infection; purchased from Chengdu Pingan Animal Breeding Base.
[0033] 1.2 Main reagents
[0034] Paraquat (abbreviated as PQ) was purchased from Shanghai Pesticide Research Institute;
[0035] Other medicines and consumables were purchased from Likang Pharmacy of West China Hospital.
[0036] 1.3 Preparation of the main solution
[0037] Solution preparation:
[0038] Take the original 1g / bottle of paraquat powder, add 1mL of physiological saline to dissolve it, and use it as a storage solution for short-term storage at 4°C. According to the weight of the monkeys, the PQ solution was incorporated into the food of the monkeys at 25 mg / kg body weight.
[0039] 1....
experiment example 1
[0085] Experimental Example 1 Constructing the dose screening experiment of animal model of secondary pulmonary fibrosis
[0086] 1. According to the model building method in Example 1, the only difference is that the dosage in "1.5.4 Paraquat Feeding Rhesus Monkey Process" was increased from 25 mg / kg to 40-80 mg / kg. It was found that the rhesus monkeys eventually developed symptoms of acute lung injury, which did not meet the modeling requirements.
[0087] That is to say, using the modeling method of Example 1, the rhesus monkey model of secondary pulmonary fibrosis cannot be successfully established when the oral administration dose is increased to 40-80 mg / kg.
[0088] 2. According to the model building method in Example 1, the only difference is that the dosage in "1.5.4 Paraquat Feeding Rhesus Monkey Process" was reduced from 25 mg / kg to 10 mg / kg, and it was found that the rhesus monkey lung The presence of an inflammatory infiltrate rather than secondary pulmonary fibr...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com